![](https://www.bctechnology.com/tmp/news/4A7FE2D1ED594266517189E7CF2F3FB0A53F118E5D1D0BE6552B86D8EA9BFA82.png?1719313248)
Zymeworks To Receive $8M Milestone Payment from BeiGene Following China NMPA Acceptance Of Biologics License Application
Zymeworks To Receive $8M Milestone Payment from BeiGene Following China NMPA Acceptance Of Biologics License Application Zymeworks Announces China NMPA Acceptance Of Biologics License Application For Zanidatamab For Second-Line Treatment Of Biliary Tract …